Identifying pain-related concerns in routine follow-up clinics following oral and oropharyngeal cancer

Table 2 Patient factors, by whether there was any evidence of significant pain from the University of Washington Quality of Life questionnaire and by whether pain issues were raised for discussion on the Patients Concerns Inventory at the first study clinic n (%)

	Patients	No significant pain and no wish to discuss pain (n = 110)	Significant pain (n = 44)	No significant pain but wish to discuss pain (n = 23)	P value1
Male	112	71 (63)	29 (26)	12 (11)	0.49
Female	65	39 (60)	15 (23)	11 (17)
Age (< 55 yr)	45	23 (51)	15 (33)	7 (16)	0.03
Age (55-64 yr)	64	35 (55)	19 (30)	10 (16)
Age (65+ yr)	68	52 (76)	10 (15)	6 (9)
Squamous cell carcinoma	158	101 (64)	39 (25)	18 (11)	0.16
Other diagnosis	19	9 (47)	5 (25)	5 (26)
Oral cavity tumor	126	83 (66)	28 (22)	15 (12)	0.71 (oral vs pharyngeal)
Pharygeal	41	20 (49)	15 (37)	6 (15)
Other site	10	7 (70)	1 (10)	2 (20)
Clinical T1/T2	140	93 (66)	31 (22)	16 (11)	0.11
Clinical T3/T4	34	16 (47)	12 (35)	6 (12)
Clinical N0	139	89 (64)	34 (24)	16 (12)	0.43
Clinical N+	36	20 (56)	9 (25)	7 (19)
Primary surgery only	103	68 (66)	26 (25)	9 (9)	0.006
Primary surgery and RT	56	32 (57)	10 (18)	14 (25)
No surgery, primary RT	18	10 (56)	8 (44)	- (-)
Within 12 months of diagnosis	73	45 (62)	20 (27)	8 (11)	0.18
Within 12-23 mo of diagnosis	23	15 (65)	6 (26)	2 (9)
Within 24-47 mo since diagnosis	37	23 (62)	10 (27)	4 (11)
48 or more months from diagnosis	44	27 (61)	8 (18)	9 (20)

¹χ² test, apart from Kruskal-Wallis test for age and time from diagnosis and using the numerical values.